See Hoe LE, Schilling JM, Tarbit E, Kiessling CJ, Busija AR, Niesman IR, Du Toit E, Ashton KJ, Roth DM, Headrick JP, Patel HH, Peart JN. Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection. Am J Physiol Heart Circ Physiol 307: H895-H903, 2014. First published July 25, 2014; doi:10.1152/ajpheart.00081.2014.-Cholesterol-rich caveolar microdomains and associated caveolins influence sarcolemmal ion channel and receptor function and protective stress signaling. However, the importance of membrane cholesterol content to cardiovascular function and myocardial responses to ischemiareperfusion (I/R) and cardioprotective stimuli are unclear. We assessed the effects of graded cholesterol depletion with methyl-␤-cyclodextrin (M␤CD) and lifelong knockout (KO) or overexpression (OE) of caveolin-3 (Cav-3) on cardiac function, I/R tolerance, and opioid receptor (OR)-mediated protection. Langendorff-perfused hearts from young male C57Bl/6 mice were untreated or treated with 0.02-1.0 mM M␤CD for 25 min to deplete membrane cholesterol and disrupt caveolae. Hearts were subjected to 25-min ischemia/45-min reperfusion, and the cardioprotective effects of morphine applied either acutely or chronically [sustained ligand-activated preconditioning (SLP)] were assessed. M␤CD concentration dependently reduced normoxic contractile function and postischemic outcomes in association with graded (10 -30%) reductions in sarcolemmal cholesterol. Cardioprotection with acute morphine was abolished with Ն20 M M␤CD, whereas SLP was more robust and only inhibited with Ն200 M M␤CD. Deletion of Cav-3 also reduced, whereas Cav-3 OE improved, myocardial I/R tolerance. Protection via SLP remained equally effective in Cav-3 KO mice and was additive with innate protection arising with Cav-3 OE. These data reveal the membrane cholesterol dependence of normoxic myocardial and coronary function, I/R tolerance, and OR-mediated cardioprotection in murine hearts (all declining with cholesterol depletion). In contrast, baseline function appears insensitive to Cav-3, whereas cardiac I/R tolerance parallels Cav-3 expression. Novel SLP appears unique, being less sensitive to cholesterol depletion than acute OR protection and arising independently of Cav-3 expression.
SARCOLEMMAL MICRODOMAINS are critical regulators of cellular function and signaling (34) and may be important in sex-, age-, and disease-dependent differences in cardiac and vascular function (3, 10, 11, 14, 24, 49, 62) . Caveolae are lipid rich (i.e., cholesterol and glycosphingolipid) microdomains containing scaffolding proteins, caveolins, that present as distinct molecular platforms for the regulation of cytoprotective and other signaling (52) . However, the importance of membrane cholesterol and microdomains to the maintenance of myocardial and coronary function as well as intrinsic responses to insult/stress and protective stimuli is unclear.
Experimental findings from different in vitro cell models have suggested the potential dependence of myocardial and coronary vascular function on membrane cholesterol content (or caveolar integrity). In isolated cardiomyocytes, cholesterol depletion with methyl-␤-cyclodextrin (M␤CD) induces a negative inotropic effect at rest (6) while enhancing contractile responses to ␤ 2 -adrenergic receptors (ARs) (6, 7, 26) and ␤ 1 -ARs (1) . In coronary smooth muscle, M␤CD impairs endothelin-1 and serotonin responses while enhancing phenylephrine contraction (40) . In other vascular smooth muscles, M␤CD enhances Ca 2ϩ -activated Cl Ϫ currents (51) , and in uterine myocytes, M␤CD amplifies large-conductance Ca 2ϩ -activated K ϩ (BK Ca ) channel currents (50) . In the vascular endothelium, M␤CD also enhances BK Ca activity to induce hyperpolarization (43) and represses agonist-mediated Ca 2ϩ entry (30) .
Despite effects of cholesterol depletion on cardiac and vascular myocyte and endothelial function in vitro, recent studies (8, 53) have reported M␤CD insensitivity of coronary and myocardial contractile function in intact hearts. Given in vitro evidence that cholesterol and caveolar depletion significantly influence molecular determinants of cardiovascular function and control, in the present study, we assessed the impacts of acute graded cholesterol depletion with M␤CD and lifelong modulation of caveolin-3 (Cav-3) [knockout (KO) and overexpression (OE)] on myocardial function, ischemia-reperfusion (I/R) tolerance, and cardioprotection via conventional, acute opoid receptor (OR) activation (acute ligand-activated preconditioning) versus novel, sustained OR activation [sustained ligand-activated preconditioning (SLP)] (35, 36, 38) . The data revealed that cholesterol depletion markedly suppresses myocardial contractile function and coronary perfusion, impairs intrinsic I/R resistance, and negates cardioprotection via acute and sustained morphine treatment. In contrast, Cav-3 KO and OE modified I/R tolerance without altering normoxic function and do not influence protection via novel SLP.
MATERIALS AND METHODS

Animals.
All experiments were approved by and performed in accordance with guidelines of the Animal Ethics Committee of Griffith University (accredited by the Queensland Government, De-partment of Primary Industries and Fisheries, under the guidelines of "The Animal Care and Protection Act 2001, Section 757") and the Institutional Animal Care and Use Committee of the Veterans Affairs San Diego Healthcare System. The generation and phenotypic details of Cav-3 KO and OE mice have been previously outlined in detail (12, 54) .
Chemicals. Morphine pellets were obtained via the National Institute of Drug Abuse (Bethesda, MD) or Murty Pharmaceuticals (Lexington, KY). All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
Induction of SLP. Mice were briefly anesthetized with isoflurane, a small incision was made at the base of the neck, and placebo or morphine (75 mg) pellets were inserted aseptically in the dorsal subcutaneous space with the site closed with 9-mm wound clips. Pellets were left in place for 5 days, after which mice were euthanized for heart excision/perfusion (35, 36, 38) .
Perfused heart preparation. Mice were anesthetized with 60 mg/kg pentobarbital sodium, and hearts removed and perfused as previously described (16, 37, 58) . Briefly, hearts were rapidly excised into ice-cold perfusion fluid, the aorta was cannulated, and the coronary circulation was perfused in Langendorff mode at a pressure of 80 mmHg with modified Krebs-Henseleit solution containing (in mM) 120 NaCl, 25 NaHCO 3, 4.7 KCl, 2.5 CaCl2, 1.2 MgCl2, 1.2 KH2PO4, 15 D-glucose, and 0.5 EDTA. The perfusion fluid was maintained at 37°C and bubbled with a mix of 95% O 2 and 5% CO2 at 37°C to provide a pH of 7.4 and PO2 of ϳ600 mmHg at the aortic cannula over a flow range of 1-5 ml/min. The perfusate was continuously passed through a 0.45-m filter. The left ventricle (LV) was vented with a polyethylene apical drain, and a fluid-filled polyvinyl chloride plastic film balloon inserted into the ventricle via the mitral valve. Balloons were connected by fluid-filled tubing to a P23 XL pressure transducer (Viggo-Spectramed, Oxnard, CA) permitting continuous assessment of contractile function. Balloon volume was increased to give an end-diastolic pressure of 5 mmHg during stabilization and was not further adjusted. Coronary flow was monitored via a flow probe in the aortic perfusion line connected to a T206 flowmeter (Transonic Systems, Ithaca, NY). Functional data were recorded at 1 kHz on an eight-channel MacLab data-acquisition system (AD Instruments) connected to an Apple iMac computer. LV pressure signals were digitally processed to yield diastolic, systolic, and developed pressures and heart rate.
After preparation, hearts were immersed in perfusion fluid at 37°C in a water-jacketed organ bath. Temperatures of the perfusion fluid and organ bath were continuously monitored by two needle thermistor probes connected to a TH-8 digital thermometer (Physitemp Instruments, Clifton, NJ). Hearts were excluded from the study if they met one of the following exclusion criteria after stabilization: 1) coronary flow Ͼ 5 ml/min, 2) unstable (fluctuating) contractile function, 3) LV systolic pressure Ͻ 100 mmHg, or 4) significant cardiac arrhythmias. This amounted to Ͻ4% of all hearts perfused.
Perfused heart experiments. Hearts were isolated from control and SLP mice. Perfused hearts were then either untreated or subjected to 25 min of treatment with 0.02-1.0 mM M␤CD after a stabilization period (20 min). Simultaneously, perfused hearts were switched to ventricular pacing at 420 beats/min (Grass S9 stimulator, Quincy, MA), with the rate normalized to permit comparison of rate-dependent measures of contractile function. Hearts were then either subjected to a 10-min period of morphine treatment (10 M) or vehicle before 25 min of normothermic global zero-flow ischemia followed by 45 min of aerobic reperfusion. Pacing and drug infusion were terminated on the initiation of ischemia with pacing only resumed at 1.5 min of reperfusion (16, 37) . Cell death in response to I/R was assessed via a spectrophotometric enzymatic assay of lactate dehydrogenase (LDH) released over the entire reperfusion period. Samples were stored at Ϫ80°C until enzymatic analysis (Cytotox 96, Promega, Madison, WI).
Simulated ischemia in HL-1 cells. To simulate I/R in cultured HL-1 myocytes, cells were switched to "ischemic" buffer containing 20 mM HEPES (pH 6.6), 125 mM NaCl, 8 mM KCl, 1.2 mM KH 2PO4, 1.25 mM MgSO4, 1.2 mM CaCl2, 6.25 mM NaHCO3, and 5 mM Nalactate in a sealed hypoxic chamber (STEMCELL, Vancouver, BC, Canada) equilibrated with 95% N2-5% CO2 for 3 h. Reperfusion was achieved by the substitution of ischemic buffer with a normoxic solution containing 20 mM HEPES (pH 7.4), 110 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2PO4, 1.25 mM MgSO4, 1.2 mM CaCl2, 25 mM NaHCO3, and 15 mM glucose equilibrated with 95% O2-5% CO2 for a further 5 h. Cells were untreated or treated with 1 mM M␤CD for 60 min before simulated I/R. LDH activity was assayed using a CytoTox 96 assay kit (Promega) according to the manufacturer's instructions. Normoxic control cells incubated with M␤CD showed no detectable cytotoxicity based on LDH changes (data not shown).
Cholesterol assay. Total cholesterol content was assayed in membrane-enriched myocardial subcellular fractions using an Amplex Red Cholesterol Assay kit (Invitrogen) according to the manufacturer's instructions. After 60 min of incubation (37°C, in the dark), fluorescence was measured using an Infinite M200 Pro microplate reader (Tecan Australia) at 530/25-nm excitation and 590/35-nm emission wavelengths. Samples were assayed in duplicate, and cholesterol levels were determined from cholesterol standard curves run daily (content normalized to micrograms of protein).
Electron microscopy. Whole hearts were perfused with standard Karnovsky's fixative of 4% paraformaldehyde and 1.5% glutaraldehyde in 0.1 M cacodylate buffer. Samples were further postfixed in 1% osmium tetroxide and en bloc stained with uranyl acetate. After dehydration, hearts were embedded in a longitudinal orientation in LX-112 (Ladd Research, Williston, VT) and polymerized at 60°C for 48 h. Blocks were then trimmed to regions of matching longitudinal orientation and thin sectioned, with sections stained in uranyl acetate and lead citrate and observed with an electron microscope (JOEL 1200 EX-II, JEOL USA, Peabody, MA, or Philips CM-10, Philips Electronic Instruments, Mahwah, NY).
Statistical analysis. All data are expressed as means Ϯ SE. Differences between groups were tested via one-way ANOVA, with a Newman-Keuls post hoc test used for paired comparisons when significant effects were detected. Significant differences were accepted for P Ͻ 0.05.
RESULTS
Cholesterol depletion with M␤CD depresses normoxic function in murine hearts.
There were no significant differences in normoxic contractile function or coronary flow in isolated perfused hearts before M␤CD treatment (Table 1) . A 25-min period of treatment with M␤CD concentration dependently depressed ventricular pressure development (Fig. 1, A and B) , involving select inhibition of systolic force at 20 M and combined diastolic and systolic actions at higher M␤CD concentrations. Coronary vascular function was much less sensitive to M␤CD, with flow only falling significantly (by ϳ30%) at the highest concentration (1 mM; Fig. 1C ). The insensitivity of coronary perfusion to 20 -200 M M␤CD demonstrates that M␤CD depresses contraction through a mechanism independent of flow.
Cholesterol depletion with M␤CD depresses I/R tolerance in murine hearts and HL-1 cells. A 25-min ischemic insult in untreated control hearts resulted in a profound elevation in postischemic end-diastolic pressure (to 28 mmHg) and blunted recovery of contractile function (LV developed pressure reaching ϳ50% of baseline function) after 45 min of reperfusion (Fig. 2, A and B) . Pretreatment with M␤CD depleted sarcolem- mal cholesterol content in postischemic hearts in a concentration-dependent manner (by ϳ10 -30%; Fig. 2C ). Electron microscopy revealed a progressive loss of caveolar structures with increasing concentrations of M␤CD, with virtually no morphologically identifiable caveolae at 200 M M␤CD (Fig. 3) . Functional recoveries in response to I/R were also impaired by M␤CD, although I/R tolerance was less sensitive to M␤CD than normoxic function: recoveries for LV diastolic function ( Fig. 2A ) and pressure development (Fig. 2B) were unaltered by 20 M M␤CD and progressively worsened with 200 M and 1 mM M␤CD. To test whether M␤CD reduces ischemic tolerance at the level of the myocyte, HL-1 myocytes (untreated or incubated with 1 mM M␤CD) were subjected to simulated I/R (Fig. 4) . Pretreatment with M␤CD doubled the impact of I/R on cellular damage, as indicated by LDH efflux.
M␤CD treatment attenuates OR-mediated cardioprotection. Preischemic treatment of perfused hearts with morphine (10 M for 10 min) significantly reduced postischemic diastolic and contractile dysfunction (Fig. 5, A and B) . Morphineinduced SLP provided even greater improvements in diastolic and contractile outcomes (Fig. 5, A and B) . Protection with acute morphine was abolished by pretreatment with Ն20 M M␤CD, whereas protection via SLP was less sensitive, only declining with Ն200 M M␤CD.
The SLP phenotype is Cav-3 independent. Selective effects of 20 versus 200 M M␤CD on I/R tolerance and cardioprotection could reflect more select caveolar disruption with modest cholesterol depletion during low-level M␤CD treatment, whereas higher levels may additionally disrupt noncaveolar membrane lipid rafts and essential membrane signaling. To assess the effects of more specific caveolar perturbation, we examined the impacts of Cav-3 KO and transgenic OE; ablation of myocardial Cav-3 eliminates caveolar structures, whereas Cav-3 OE increases caveolar density (18, 19, 54, 55) .
Neither KO or OE of Cav-3 altered normoxic contractile function or coronary flow in isolated perfused hearts (Table 2) , in contrast to the inhibitory effects of M␤CD. However, Cav-3 KO significantly exaggerated postischemic diastolic dysfunc- tion and LDH efflux in perfused hearts (Fig. 6, A-C) . Conversely, Cav-3 OE significantly improved postischemic functional outcomes without altering LDH efflux (Fig. 7, A-C) . Deletion of Cav-3 failed to attenuate the cardioprotective effects of morphine-dependent SLP (Fig. 6) , and SLP significantly improved postischemic recoveries in Cav-3 OE hearts (Fig. 7) . Manipulation of Cav-3 expression and treatment with M␤CD thus induced both common and distinct cardiac outcomes: M␤CD repressed normoxic function, whereas Cav-3 KO did not, and M␤CD and Cav-3 KO both impaired protection via acute OR agonism, whereas SLP was only sensitive to M␤CD.
DISCUSSION
The results of the present study highlight the importance of sarcolemmal cholesterol and membrane microdomains to the maintenance of myocardial contractile function and resistance to I/R. The ability to protect the heart against I/R injury via OR-targeted stimuli is also selectively modified by changes in membrane cholesterol and Cav-3. Distinguishing novel SLP from conventional protection (e.g., via acute OR activation), this conditioning response was shown to be less sensitive to cholesterol depletion and appears entirely Cav-3/caveolae independent.
Role of membrane cholesterol in the maintenance of cardiovascular function. The present data revealed significant contractile and vascular alterations in hearts perfused with the cholesterol-depleting agent M␤CD (Fig. 2) . Inhibitory effects of M␤CD are concentration and parameter dependent: the myocardial response specifically involves systolic depression at low M␤CD (with both diastolic and systolic changes at higher concentrations) and is substantially more M␤CD sensitive than coronary function. These findings contrast with recent reports of unaltered normoxic function in perfused hearts treated with 200 M (8) or 1 mM (53) M␤CD. The basis for this difference is unclear, with all studies using isolated perfused rodent hearts and similar ranges of M␤CD concentration. However, repression of contractile function is consistent with the significant influences of membrane cholesterol and caveolae on a variety of ion channels, receptor function and signaling, and other physiological processes (3, 4, 13, 22) .
The membrane cholesterol dependence of function in intact hearts (Fig. 1 ) agrees with prior in vitro observations, although mixed effects of cholesterol depletion with M␤CD have been reported. For example, L-type Ca 2ϩ channels, ␤ 2 -AR, adenylyl cyclase, and PKA colocalize in caveolar macrocomplexes governing channel function and cell signaling in ventricular myocytes. Similarly, cholesterol depletion has been reported to reduce myocyte Ca 2ϩ currents and contraction under baseline conditions (6) and inhibit effects of ␤ 2 -AR activity (2, 6) . Nonetheless, other studies have identified amplified ␤ 1 -AR or ␤ 2 -AR signaling upon myocyte cholesterol depletion, with enhanced PKA/adenylyl cyclase phosphoregulation of target proteins (e.g., phospholamban and troponin I), and activation of Ca 2ϩ currents and myocyte contractile function (1, 7, 26 ). While we do not address ␤-AR responsiveness, our data for intact perfused hearts are consistent with inhibitory rather than stimulatory effects of cholesterol depletion on Ca 2ϩ -dependent myocyte function (3, 6) . The absence of an effect of Cav-3 KO or OE on normoxic function suggests that cholesterol depletion impacts cardiac function via mechanisms additional to caveolar disruption. However, it is also possible that adaptation within the membrane signaling compartment occurs with lifelong changes in Cav-3, compensating for cardiac functional changes (whereas acute disruption with M␤CD cannot be accommodated in such a manner). While M␤CD has also been reported to induce cytotoxicity in some cell types (17) , this is an unlikely explanation for contractile depression since cardiac effects of M␤CD can arise at a low concentration (20 M), three orders of magnitude lower than levels inducing cytotoxicity in vitro (17) . Moreover, functional effects of M␤CD are selective, impacting systolic versus diastolic force without influencing coronary function.
Caveolae and cholesterol are implicated in vascular control, and we observed repression of coronary flow with the high concentration (1 mM) of M␤CD. In coronary and other vascular smooth muscles, M␤CD treatment modifies ion channel function (BK Ca and Ca 2ϩ -activated Cl Ϫ currents) and receptordependent control of intracellular Ca 2ϩ concentration and vascular tone (40, 47, 51) . M␤CD also modifies BK Ca currents in nonvascular smooth muscle (50) , together with BK Ca activity (43) and agonist-mediated Ca 2ϩ entry (30) in the vascular endothelium. Interestingly, M␤CD treatment diminishes storeoperated Ca 2ϩ channel function (where the reduction in intracellular Ca 2ϩ stores activates Ca 2ϩ influx) and attenuates the hypertensive phenotype (associated with elevated caveolae/ caveolin levels) in pulmonary arteries from patients with idiopathic pulmonary arterial hypertension (33) . The basis of the reduction in coronary perfusion, observed at the highest level of M␤CD treatment, is unclear. Coronary sensitivity to the cholesterol-depleting agent is substantially lower than cardiac sensitivity; however, cardiac changes could contribute to the vascular response. The substantial ϳ20-mmHg rise in diastolic pressure with 1 mM M␤CD will limit coronary perfusion via 
Data are means Ϯ SE. Values were recorded before pacing. Cav-3, caveolin-3.
diastolic compression, whereas the 40% fall in ventricular pressure development will reduce myocardial work and thereby O 2 demand. Thus, M␤CD may selectively impair myocardial versus coronary vascular function, with reduced coronary flow reflecting cardiac compression coupled with reduced "metabolic" vasodilatation. Importance of membrane cholesterol and Cav-3 to I/R tolerance. The present study revealed common and qualitatively differing effects of M␤CD and Cav-3 KO on myocardial I/R tolerance. Since M␤CD depletes membrane cholesterol (impacting caveolae together with planar lipid rafts), whereas Cav-3 KO selectively depletes caveolae (without altering other cholesterol-dependent domains, such as lipid rafts, which may still be intact and regulate components of the protective signaling pathway), these data support distinct roles for different membrane compartments and highlight the importance for membrane cholesterol content in the regulation of myocardial I/R tolerance. Acute depletion of membrane cholesterol by Ն20% worsens both postischemic diastolic contracture and contractile depression (Figs. 2 and 5 ). In contrast, chronic Cav-3 depletion selectively exaggerates diastolic dysfunction and LDH release without impacting force development (Fig.  6 ). These differences suggest important requirements for Cav-3/caveolae in limiting cell death and diastolic contracture (the latter directly or as a result of altered cell death), whereas non-caveolar domains are additionally important in influencing contractile depression or "stunning." Curiously, while increased Cav-3 expression did improve I/R tolerance (Fig. 7) , this involved enhanced contractile outcomes with no shift in cell death. Thus, although Cav-3/caveolae appear critical to intrinsic resistance to cell death/diastolic dysfunction, an ex- cess of Cav-3 represses mechanical stunning without providing further protection against death.
The declining I/R tolerance is not unexpected given the influences of caveolae and cholesterol on key determinants of stress resistance (8, 18, 31, 32, 44, (52) (53) (54) (55) (56) (57) . For example, M␤CD consistently inhibits BK Ca channel function across different cell types, and the channel has been implicated in cytoprotection and I/R injury. Similarly, ␤ 2 -AR function is consistently perturbed by cholesterol depletion, and these receptors are also cardioprotective (5, 9) . Nonetheless, the present study contrasts with those of Das et al. (8) and Sun et al. (53) , in which no changes in I/R tolerance (or normoxic function) were observed after M␤CD treatment. The reasons for this discrepancy are unclear, although we note consistent exaggeration of I/R injury in both intact hearts and cultured HL-1 cells (Fig. 4) , supporting a select cardiac effect.
Importance of membrane cholesterol and Cav-3 in ORmediated cardioprotection. Growing evidence indicates that caveolins and caveolae are crucial determinants of the efficacy of cytoprotective stimuli (15, 18, 32, 54 -56) . We examined the effects of membrane disruption with M␤CD on two cardioprotective responses initiated by ORs yet mediated by distinct mechanisms (36) : acute (conventional) OR-induced protection and novel OR-induced SLP. Acute OR protection was lost in hearts exposed to Ն20 M M␤CD, whereas protection via SLP was more resistant, only declining at Ն200 M M␤CD (Fig. 5) . This supports mechanistically distinct protection via chronic versus acute OR activation. Previous studies have shown that cardioprotective responses induced via ischemic preconditioning, acute OR agonism, and volatile anesthetic treatment are all negated by M␤CD treatment (18, 31) or caveolar disruption through caveolin KO (32, 54) . This may reflect select disruption of caveolae (and dependent G proteincoupled receptors) at low M␤CD levels versus more widespread disruption of membrane lipid rafts at higher concentrations. Non-caveolar planar lipid rafts may be equally important in the membrane signal transduction underlying cytoprotective responses (44, 52) . It is also important to note that acute and sustained OR stimuli differ in terms of the timing of OR involvement. For SLP, we here assessed the effects of acute M␤CD on the signaling mediating protection downstream of and subsequent to OR agonism (36) . In contrast, in the case of acute morphine, we tested the effects of M␤CD on both the initiation of OR activity and subsequent signaling events mediating protection. Thus, the greater sensitivity of acute OR protection to M␤CD likely reflects the disruption of initial caveolae/Cav-3-dependent OR activity (blocking the initial induction of protection). In contrast, since ORs are not involved in the mediation of protection in SLP hearts (36) , there was no impact of low-level M␤CD. The effects of higher M␤CD on both acute and SLP responses likely reflect "noncaveolar" effects involving other membrane-dependent determinants of cardioprotection.
The observations from the M␤CD experiments concur with the effects of Cav-3 KO. SLP dramatically improved postischemic functional recovery in KO hearts, indicating that the efficacy of SLP is neither Cav-3 or caveolae dependent. This is consistent with the additivity of cardioprotection via SLP and Cav-3 OE. A previous report (38) has indicated that SLP is also additive with different adenosinergic stimuli. Moreover, SLP is PKA dependent (36). Wang et al. (57) reported that simultaneous activation of AMP-activated protein kinase and PKA in Cav-3 KO mice significantly reduced infarct size and contractile dysfunction, providing some insight into the potential mechanisms of SLP in Cav-3 KO hearts.
Importantly, the efficacy of SLP in Cav-3 KO mice (and resistance to low-dose M␤CD) indicates that the ␦-ORs engaged during morphine pretreatment (38) are Cav-3 independent and that the mediation of protection during I/R also involves Cav-3-independent signaling. Data remain mixed regarding the caveolae and Cav-3 dependence of ␦-ORs. We have shown that myocardial ␦-ORs are localized with Cav-3 in caveolae, with caveolar disruption with M␤CD (31) and Cav-3 KO (55) eliminating acute ␦-OR-mediated protection. This is consistent with the elimination of acute morphine protection with M␤CD in the present study (Fig. 5) . Huang et al. (20) also reported that M␤CD impairs ␦-OR activity in neuronal cells (where the receptor localizes to lipid rafts) yet enhances signaling in transfected Chinese hamster ovary cells. In contrast, ␦-ORs expressed in human embryonic kidney-293 cells are reportedly insensitive to M␤CD, whereas -OR function is cholesterol dependent (23) . The caveolar/Cav-3 dependence of ␦-OR function is clearly cell type specific. Since myocardial ␦-ORs appear to be M␤CD/Cav-3 dependent (31, 55) , the preservation of SLP in Cav-3 KO mice implicates noncardiac ␦-ORs in the induction of cardioprotection. This is consistent with evidence showing that peripheral ORs can mediate cardiac preconditioning (48) and with the potent cardioprotective effects of central/spinal cord ORs (25, 59, 60) . The potential extracardiac localization of ␦-ORs engaged in protective SLP warrants further investigation.
Our data demonstrate that mechanisms mediating protection with SLP are distinct from those in conventional protection, being less sensitive to cholesterol depletion than the acute OR response and apparently independent of Cav-3 expression and caveolae. Thus, while ␤ 2 -ARs and PKA have been implicated in SLP (36, 38) , the present observations indicate that the effects of such mediators are Cav-3/caveolae independent yet sensitive to high levels of M␤CD/cholesterol depletion. This seems at odds with data demonstrating the dependence of ␤ 2 -AR signal transduction on cholesterol-rich caveolae (29, 45, 61) . However, other studies have indicated that only a small fraction of ␤ 2 -ARs concentrate within caveolae (21, 39) , with cholesterol depletion augmenting (rather than limiting) ␤ 2 -AR signaling (21, 27, 28, 41, 45, 46) . Further work is clearly required to resolve the influences of cholesterol levels and caveolae on cardiac ␤ 2 -AR signaling and the mechanisms underpinning ␤ 2 -AR/PKA-dependent yet Cav-3/caveolae-independent SLP. Since cholesterol is an important component of the entire membrane, including non-caveolar domains, the present data indicate that other functional compartments play an important role.
Summary. The present study reveals that myocardial contractile function and I/R tolerance are highly sensitive to membrane cholesterol depletion, whereas lifelong/chronic disruption of caveolae (via Cav-3 manipulation) selectively modifies I/R tolerance without influencing cardiac function. These data indicate that shifts in membrane cholesterol content and/or caveolar function, with age or disease for example, may be important determinants of myocardial dysfunction and injury processes. Finally, the present data confirm a distinct mecha-nistic basis for protective SLP, which is less sensitive to cholesterol depletion than conventional protection and arises independently of caveolae/Cav-3. Further investigation is required to clarify the mechanistic basis of, and role of membrane cholesterol in, cardioprotective SLP.
